clofibric acid has been researched along with Cerebrovascular Disorders in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwiesow, SJ | 1 |
| Nappi, JM | 1 |
| Ragucci, KR | 1 |
| Olivella, J | 1 |
| Vicens, B | 1 |
1 trial available for clofibric acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
Plafibride: clinical trial of a new platelet antiaggregating agent.
Topics: Adenosine Diphosphate; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Clofib | 1981 |
1 other study available for clofibric acid and Cerebrovascular Disorders
| Article | Year |
|---|---|
Assessment of compliance with lipid guidelines in an academic medical center.
Topics: Academic Medical Centers; American Heart Association; Angioplasty, Balloon, Coronary; Cerebrovascula | 2006 |